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INTRODUCTION 
The ongoing obesity epidemics is currently a serious 
health concern.
1
 Most lifestyle interventions fail over 
time, and people inexorably regain the lost weight after 
about 6-12 months.
2-3 
Usually, overweight/obese 
individuals resume wrong lifestyle habits, such as 
overeating, unhealthy diets, and physical inactivity.
4 
Overeating often involves loss of control and compulsive 
behaviors;
5
 habits, time of the day, social situations, 
convenience, hunger/taste, mood or stress and genetics 
are all factors which can determine the extent and type of 
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the meals, often overcoming known homeostatic 
mechanisms, including gastrointestinal and central 
nervous system satiation signals.
6
 Both the emotional 
eating, i.e. the automatic tendency to eat in order to 
suppress negative thoughts and feelings
7-9
 and the reward 
mechanisms by which obese individuals seek pleasure by 
foods are well described conditions, leading to a sort of 
food addiction.
10 
These mechanisms are mediated by 
multiple areas in the brain that seem to be hyper-
responsive to food and emotional stimuli in obese 
subjects.
5,11,12
 
Psychological factors are often disregarded in the 
treatment of obesity despite growing evidence of their 
pathogenetic role.
13,14
 In addition to traditional 
psychotherapeutic treatments, promising non-verbal 
interventions are increasingly used, such as the 
mindfulness technique.
15
 This topic is receiving 
increasing research and clinical interest.
16
 It is described 
as a state of self-regulated attention to a current 
experience with the goal of achieving a non-elaborative 
awareness of it.
17
 Many studies have supported the 
benefits of mindfulness-based interventions to control 
some obesity-related behaviors, including binge eating, 
emotional eating, externally-induced eating, and to 
promote weight loss maintenance.
18
 
Hypnosis has been considered either “a distinct state of 
consciousness” or a normal state with heighten 
suggestibility determined by social influence combined 
with a set of cognitive-behavioral skills.
19
 The core 
components of hypnosis involve reduced awareness of 
external stimuli, increased responsiveness to hypnotic 
suggestions, deep relaxation, increased capacity to 
enhance mental representations, and absorption in 
hypnotic suggestions.
20,21
 Suggestions may be verbal and 
non-verbal communications that can be used to influence 
mood, behavior, and habits.
22,23
 Hypnosis has been used 
in medicine for different purposes: the control of acute 
and chronic pain, support during labor, smoking 
cessation, anxiety alleviation, treatment of conversion 
disorders, schizophrenia and insomnia, with mixed 
results.
24-27
  
Indeed, hypnosis could be considered as another 
therapeutic possibility, like mindfulness, by increasing 
the ability to control emotional impulses.
28
 Self-
conditioning techniques borrowed from hypnosis (self-
hypnosis) increase self-control and self-management of 
emotions, with the patient fully awake and conscious. 
Recent hypnosis techniques with a rapid-induction phase 
allow the patient to go into hypnosis in a few minutes. 
Therefore, trained subjects are able to repeat the 
experience in complete autonomy, in several moments, 
employing a short time of the day only.  
It could be hypothesized that self-hypnosis could be 
applied before meal or snack times, and, in general, 
during each circumstance of irrational need of foods. 
Indeed, very often people begin their meals with the 
stress and worries of the day, thus eating in less 
conscious way, often gorging, without being able to 
control themselves.  
We will test whether a training to teach self-conditioning 
technique (self-hypnosis) added to traditional approach 
(diet, exercise and behavioral recommendations) will be 
effective in determining weight loss with respect to the 
traditional approach in patients with obesity. 
METHODS 
Trial design and participant enrolment 
We planned the execution of a prospective, randomized 
controlled, open-label monocentric trial. It will be 
performed in patients with a BMI between 35 and 50 
Kg/m
2
 by comparing an experimental group, in which 
self-conditioning techniques will be added to usual care, 
to a control group who will be treated only with the 
traditional care, i.e. the combination of diet, exercise and 
behavioral recommendations.  
The trial will be conducted at the Obesity Unit of the Unit 
of Clinical Nutrition of the “Città della Salute e della 
Scienza” Hospital of Turin (North-Western Italy).  
The trial is registered at ClinicalTrials.gov (identifier 
NCT02978105) and has received ethical approval from 
the ethics committee of “Città della Salute e della 
Scienza” of Turin; all the procedures will be conducted in 
agreement to the principles of the Helsinki Declaration. 
All participants will provide written informed consent to 
take part to the study. 
The trial will include participants recruited by 
nutritionists and dieticians from outpatients of the 
Obesity Unit with a body mass index (BMI) value 
between 35 and 50 kg/m
2
, with an age range 25-70 years, 
without any exclusion criteria as presented in Table 1. 
 Table 1: Eligibility criteria. 
Inclusion criteria 
• Ability to give written informed consent  
• BMI between 35 and 50 kg/m2 
• Age 20-70 years 
Exclusion criteria 
• Current or previous mental disorders and/or on 
any psychotropic drug 
• Insulin treatment 
• Candidates for bariatric surgery 
• Current (or discontinued for less than 6 months) 
treatment with anti-obesity drugs 
• Patients at risk of heart failure, edema, ascites 
(heart diseases, chronic liver diseases, nephrotic 
syndrome, renal failure) 
• Patients with untreated or uncompensated thyroid 
diseases 
Bo S et al. Int J Clin Trials. 2017 Feb;4(1):20-27 
                                                             International Journal of Clinical Trials | January-March 2017 | Vol 4 | Issue 1    Page 22 
The subjects preliminarily identified in this way will be 
further submitted to the following questionnaires: 
 The Hamilton rating scale for depression.29 
 The Hamilton rating scale for anxiety.30 
 The Binge Eating Scale.31 
 
Only individuals who will satisfy all scores [respectively 
<8 (Hamilton depression scale), <17 (Hamilton anxiety 
scale) and <17 (Binge Eating scale)] will be enrolled, 
after obtaining informed written consent 
Outcomes 
Patients who are eligible for the study will be randomized 
to one of the following arms: experimental arm (self-
conditioning techniques + standard care) and control arm 
(standard care, i.e. diet + exercise + behavioral 
recommendations) as shown in Figure 1.  
 
Figure 1: Flow of the study. 
The Primary outcome is the difference between groups in 
weight loss at 12 months after randomization.   
The Secondary outcomes are the variations in: 
 Adherence to the diet (3-day food records) 
 Physical activity level (Minnesota questionnaire)32 
 Appetite (Satiety Labeled Intensity Magnitude 
scale)
33
 
 Satisfaction and well-being (EuroQol (EQ)-5 
questionnaire [Index and Visual Analog Scale 
(VAS)]
34
 
 Waist circumference and body fat percentage 
 Arterial blood pressure (and/or use of anti-
hypertensive drugs) 
 Fasting glucose, glycated hemoglobin (and/or use of 
hypoglycemic drugs) 
 Fasting insulin and insulin resistance [index 
Homeostasis Model Assessment-Insulin resistance 
(HOMA-IR)]
35
 
 Total cholesterol and HDL-cholesterol, triglycerides 
(and/or need for lipid-lowering drugs) 
 Markers of inflammation [C-reactive protein (CRP)] 
 Incident diseases and/or need for new drugs 
 Evaluation the average weekly frequency use of self-
conditioning in the experimental arm only. 
Randomization 
The list of randomization, stratified by age (50; > 50 
years), gender, BMI (40; > 40 kg/m
2
) will be generated 
by using a variable-length block procedure, masked to 
researchers who enroll the patients. The randomization 
procedure will be centrally run through an online 
procedure (available at: http://www.epiclin.it). At 
enrollment, a unique code will be assigned to each 
patient. After the randomization procedure, the patient 
will be assigned to the experimental or control arm, and 
the change of the arm to which the patient has assigned is 
no longer possible. 
Intervention and follow-up 
The following recommendations will be provided to all 
the participants: 
Diet  
Personalized diet, with a caloric intake of approximately 
1500100 kcal/day (15-20% protein, 55-60% 
carbohydrates; 25-30% lipids); 
Exercise 
At least 20 minutes of brisk walking every day according 
to the criteria of the Borg scale (target rating 12-14)
36
 
Behavioral recommendations 
Verbal and written suggestions on how to put the exercise 
in daily activities and how to follow one’s diet with the 
help of simple tips (i.e. don't buy foods on an empty 
stomach, do not do anything else when eating, lay your 
cutlery between mouthfuls, etc).  
The use of anti-obesity drugs will be prohibited during 
the trial course. The experimental group will receive 3 
individual sessions of hypnosis, performed by trained 
personnel (2 nurses and 1 medical doctor). To minimize 
the potential lack of fidelity, the health care providers 
will be assigned to the sessions by a scheduled rotation 
among sessions to ensure a balanced intervention for all 
the subjects, and the delivered intervention will be 
checked every session. Rapid-induction techniques will 
Bo S et al. Int J Clin Trials. 2017 Feb;4(1):20-27 
                                                             International Journal of Clinical Trials | January-March 2017 | Vol 4 | Issue 1    Page 23 
be used, allowing the patient to go into a hypnotic 
condition in a few minutes.
37
 The timing and the structure 
of the sessions are reported in Table 2 and Table 3, 
respectively. 
The degree of susceptibility to hypnosis will be evaluated 
through the first part of the test of Spiegel (eyeroll) and 
by the changes in body parameters occurring during the 
hypnotic sessions.
38
 This will be then correlated with the 
outcome achieved in the experimental group.  
 
Table 2: Time points of assessments.  
Table 3: Technique of the hypnotic procedure. 
Session Phase  
1 
Introduction 
to the session 
(10 minutes) 
-greetings and mutual presentations (the hypnotist, after listening to a few sentences and 
having observed the subject, chooses the best suited method of hypnosis induction for each 
subject) 
-information about what medical hypnosis is and its potential application as an 
amplification of personal resources to manage self-control  
-Spiegel test to assess the degree of subject’s susceptibility to hypnosis 
 
Hypnotic 
induction 
(10 minutes) 
-induction by a technique of attention focusing (fixing a point or focusing the attention on a 
part of one’s body) 
-ratification of what is happening 
-phase of full-body relaxation  
-phase of slow breathing 
- imagining pleasant images and thoughts and creating an ideal "safe place" in which the 
subject can take refuge whenever he/she feels the need to. In this imaginary place, the 
subject can feel stronger, more determined, self-controlled and fit, efficient and dynamic. In 
particular, he/she will be able of doing things that previously create some difficulties, such 
as appearing in public without shame, climbing stairs, sit down at table with the knowledge 
of what he/she is about to eat, refrain from gorging, etc. 
-anchor phase: the subject receives a self-conditioning signal (i.e. joining the thumb with 
index, or making the fist with the thumb folded inside the hand, etc.) by which he/she can 
rapidly fall under hypnosis in complete autonomy 
-anchor verification stage: the subject is trained to come in and go out from hypnosis alone 
when desired  
 
Instructions 
for use 
(10 minutes) 
-information on how to use the anchor signal to enter into hypnosis and on all possible 
applications of self-hypnosis 
-instructions on how hypnosis should be used before each main meal for about three 
minutes (10 seconds to enter, 2 minutes and a half of “safe place” thinking, with muscle 
relaxation and mental well-being and 30 seconds to exit) 
-instructions on how self-hypnosis can be used in case of food compulsion 
2-3 
Reinforcement 
sessions 1 and 
3 months after 
the first 
session 
(20-30 
minutes) 
-participants’ reporting of difficulties, problems, barriers and benefits with self-hypnosis (5 
minutes) 
-check of the subjects’ skill of going into hypnosis  
-a new image will be evoked relative to the subjects’ power to face difficulties (a 
metaphorical climb on top of a mountain by overcoming natural obstacles) (10 minutes). 
The same suggestions described above will be evocated.  
-instructions for correcting mistakes and overcoming the barriers and problems encountered 
(5-15 minutes) 
    Study time-points (months) 
 
0 0.5 1.5 3  3.5  6 9 12 
Enrolment/Randomization X        
Written informed consent X        
Blood sample collection X       X 
Physical assessment X   X  X X X 
Dual Energy X-ray Absorptiometry X       X 
Dietary and exercise questionnaires X       X 
Hypnosis sessions (for experimental arm only) 
 
X X  X    
Recording of adverse events/compliance check    X  X X X 
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The hypnotic sessions have a common core, but the 
method of hypnosis induction will be individualized on 
the basis of participant characteristics. Hypnosis will be 
induced with a technique based on focus of attention and 
early ratification of the obtained effects.
39
 Participants 
will be taught how to get back in hypnosis by means of a 
signal: at the end of the induction hypnotic session, an 
“anchor” (a symbolic signal) will be given to each 
participants. At any time, by repeating this anchor the 
subject will be able to go into hypnosis again in complete 
autonomy (self-hypnosis), also repeatedly during the day.  
The acquired ability to go back in and exit from hypnosis 
by oneself will be checked-out in real time. Instructions 
on how to apply self-hypnosis before every meal and 
every attack of food compulsion will be given. 
The hypnotic induction session will last 10 minutes and 
will be focused to provide the patient with a tool to help 
him to maintain self-control towards food. All the 
subjects enrolled in the trial will be assessed at three, six, 
nine and twelve months after randomization as seen in 
Table 2. 
Quality control 
The acquired skill of the patients of the experimental arm 
will be checked by the hypnotists during each session, by 
evaluating some body parameters: 
 One or more typical changes (i.e. Muscle inertia with 
inability to move a body part, levitation, catalepsy) 
 The characteristic physical appearance of the subject 
(variation of facial expression, movements of eyelids 
and eyeballs, swallowing, changes in respiratory rate, 
vasodilation, reduced muscle tone) 
 Alteration of consciousness (the patient reports well-
being, partial detachment from reality, time warp, 
realistic images and conceived situations).  
The hypnotic condition will be reached if all the above 
reported conditions occur simultaneously. Furthermore, 
the patients’ skill will be tested by asking them to show 
the effectiveness of the anchor signal and by reevaluating 
the quality of the above described changes after self-
induction during each session. In the second and third 
sessions, participants of the experimental arm shall report 
the efficacy and persistence over time of his/her skill to 
go into hypnosis, the adherence to behavioral 
prescriptions received and the effectiveness in getting a 
sense of well-being. If a low hypnotizability is detected, 
the patient will still be encouraged to run the procedure 
before each meal and food compulsion attack. 
Endpoints and measurements 
The evaluated endpoints and the corresponding 
measurements are reported in Table 4. 
Blinding 
Because of the nature of the intervention, blinding 
participants and health professionals will not be possible. 
Personnel who perform the laboratory analyses and 
collect data will be blinded to the arm assignment.  
Drop-out 
The following will be considered as dropouts: 
 Subjects who will withdraw from the study before 12 
months for any reasons (change of residence, 
dissatisfaction/intolerance with the recommendations 
provided, etc.)  
 Subjects taking slimming products/drugs  
 Subjects using techniques to lose weight other than 
those recommended (e.g. very low calorie diets, or 
highly unbalanced diets, etc). 
Safety 
Adverse events and compliance with the study protocol 
will be monitored during each visit. Participants will be 
instructed to inform the researchers if adverse effects 
occur. These cases will be then communicated to the 
statisticians, who will monitor the safety of the study. 
Sample size 
The sample size has been calculated in relation to the 
primary outcome.  Available data on patients with 
clinical characteristics similar to those required for 
patient enrolment were used to calculate the sample 
required. The parameters used were:  
 2 tailed α-error = 0.05 
 β-error = 0.10 
 Average baseline weight = 120 Kg (SD= 15 Kg) 
 Expected weight reduction at 12 months = 10 Kg 
(Effect size = 0.67)  
With these assumptions 48 patients per arm are needed; 
this number was increased to a total of 120, in 
consideration of the possibility of drop-outs.  
Statistical analyses 
Statistical analysis will be conducted in agreement with 
the intention to treat principle. Demographic and baseline 
characteristics will be described for the entire study 
cohort. Discrete variables will be summarized by 
frequencies and percentages. Continuous variables will 
be summarized with standard measures of central 
tendency and dispersion (mean and standard deviation or 
median and interquartile range). The analysis of the 
primary endpoint will be based on the comparison 
between the two arms of the weight change from baseline  
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to 12 months after randomization. The averages of 
within-subject weight differences will be compared 
between the two arms by a linear regression model, 
including the weight values at baseline. As sensitivity 
analysis, additional potential confounding detected at 
baseline will be included in the regression model.  In the 
experimental arm, the weight difference from baseline by 
degree of susceptibility to self-hypnosis will be also 
assessed. The same methods will be employed in the 
analyses of the secondary outcomes. 
Table 4: Primary and secondary endpoints. 
Primary endpoint Measurement 
Weight loss at 12 months 
Mechanical column scale (SECA Model 711, SECA, Hamburg, Germany), 
with the participants wearing light clothes and no shoes 
Secondary  endpoint  
Adherence to the diet 3-day food record  
Level of physical activity Minnesota questionnaire [32] 
Appetite Satiety Labeled Magnitude Intensity scale [33] 
Life and health quality 
EuroQol (EQ)-5D [Index and Visual Analog Scale (VAS)] questionnaire 
[34] 
Body fat % Dual-energy X-ray absorptiometry (DXA) 
Waist (cm) Plastic tape meter immediately above the iliac crest 
Arterial blood pressure (mmHg) 
Two measurements by a mercury sphygmomanometer in a sitting position 
after at least 10 min rest 
Fasting blood glucose (mg/L)  Enzymatic method with hexokinase (Roche Diagnostic, Germany) 
Glycated hemoglobin (mmol/mol) 
Non-porous ion-exchange high performance liquid chromatography (HPLC) 
(G8 Analyzer, TOSOH, USA) 
Insulin (µU/mL) Enzyme immunoassay (Siemens, Germany) 
Insulin resistance (Homeostasis Model 
Assessment Insulin resistance index) 
[35] 
Total cholesterol (mg/dL) Enzymatic colorimetric assay (Roche Diagnostic, Germany) 
HDL cholesterol (mg/dL) Enzymatic colorimetric assay (Roche Diagnostic, Germany) 
C-reactive protein (mg/L) Particle-enhanced turbidimetric immunoassay (Roche Diagnostic, Germany) 
Triglycerides (mg/dL) Enzymatic colorimetric assay (Roche Diagnostic, Germany) 
Diseases incidence and/or new drugs Interview 
Evaluation (in the experimental group 
only) of the average weekly frequency of 
use of self-hypnosis 
Interview 
 
DISCUSSION 
Influencing a person to change his/her behavior is very 
difficult, since changes in internal motivations are 
required.
40
 The role of hypnosis as an effective tool for 
producing behavioral changes in patients with 
overweight/obesity has been evaluated by old studies, 
most of which with methodological limits, such as a low 
number of participants, the lack of a control group, the 
high percentage of dropouts, the heterogeneity of 
patients, the short-term follow-up, variations in 
procedures and different measures of response.
40-44
 
Overall, the use of hypnosis seems to provide some 
additional benefit increasing over time when added to a 
weight reduction program, but the results are still highly 
controversial. Indeed, the need for more rigorous research 
has been emphasized by all the reviews on this topic.
40-44
  
A rapid induction technique of hypnosis has developed 
some years ago.
37,39
 This allows to administer behavioral 
and awareness recommendations in a hypnotic context in  
 
a short time interval, making this method easily 
applicable for trained patients in everyday life.  
This approach seeks to maintain over time the change to a 
healthy lifestyle, since most overweight/obese patients 
are not able to keep these habits at the end of educational 
interventions. 
The results of this randomized clinical trial will 
determine if a self-conditioning approach, based on self-
hypnosis, is able to help participants to disadopt 
unhealthy patterns of eating and sustain weight loss in the 
long term. 
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